Table 1. Distribution of baseline factors according to treatment group.
| Full sample | Active group | Treatmentas usual | P-value | |
| N | 213 | 106 | 107 | |
| Male (n, %) | 156 (73%) | 78 (74%) | 78 (73%) | NS* |
| Age in years (mean, SD) | 62 (8.1) | 62 (8.1) | 62 (8.2) | NS |
| Psychometrics | ||||
| MDI (mean, SD) | 8.9 (7.4) | 8.4 (7.7) | 9.4 (7.0) | NS |
| WHO-5 (mean, SD) | 65 (19) | 67 (19) | 63 (19) | NS |
| PPS (mean, SD) | 81 (13) | 81 (13) | 81 (13) | NS |
| SF-36 PCS (mean, SD) | 48 (8.4) | 48 (9.1) | 48 (7.6) | NS |
| SF-36 MCS (mean, SD) | 52 (9.3) | 53 (9.3) | 52 (9.3) | NS |
| CSS (mean, SD) | 9.7 (7.1) | 9.2 (6.5) | 10 (7.6) | NS |
| Social status | ||||
| Married or cohabiting (n, %) | 175 (82%) | 83 (78%) | 92 (86%) | NS |
| Have children (n, %) | 190 (92%) | 97 (91%) | 96 (90%) | NS |
| Employment status | ||||
| Employed (n, %) | 106 (50%) | 54 (51%) | 52 (49%) | NS |
| Unemployed (n, %) | 4 (2%) | 3 (3%) | 1 (1%) | NS |
| Retired (n, %) | 92 (47%) | 46 (44%) | 52 (48%) | NS |
| Cardiac variables | ||||
| Selfreported time (years) since diagnosed with IHD (mean, SD) | 7.5 (5.8) | 8.2 (6.5) | 6.8 (5.0) | NS |
| Treated with PCI (n, %) | 147 (69%) | 73 (69%) | 74 (69%) | NS |
| Treated with CABG (n, %) | 52 (24%) | 27 (25%) | 25 (23%) | NS |
| Resting pulse (mean, SD) | 61 (11) | 61 (11) | 60 (11) | NS |
| MAP (mean, SD) | 98 (10) | 98 (9.7) | 97 (11) | NS |
| Cardiac risk factors | ||||
| BMI (mean, SD) | 27.6 (4.3) | 27.8 (4.3) | 27.4 (4.4) | NS |
| Triglyceride (mean, SD) | 1.5 (0.9) | 1.4 (0.7) | 1.5 (1.0) | NS |
| Current smoker (n, %) | 22 (10%) | 9 (9%) | 13 (12%) | NS |
| Self reported co-morbidity | ||||
| Heart failure (n, %) | 72 (34%) | 29 (27%) | 43 (40%) | P = 0.047 |
| Chronic obstructive lung disease (n, %) | 13 (6%) | 5 (5%) | 8 (8%) | NS |
| Diabetes (n, %) | 28 (13%) | 20 (19%) | 8 (8%) | P = 0.013 |
| Previous cerebral insults (n, %) | 15 (7%) | 7 (7%) | 8 (8%) | NS |
| Have been treated for depression (n, %) | 32 (15%) | 12 (11%) | 20 (19%) | NS |
| Medication | ||||
| Beta-blockers (n, %) | 125 (60%) | 65 (61%) | 60 (57%) | NS |
| Cholesterol-lowering medication (n, %) | 188 (90%) | 94 (89%) | 94 (88%) | NS |
| Calcium antagonists (n, %) | 47 (23%) | 26 (25%) | 21 (20%) | NS |
| Angiotensin-II antagonist and/or ACE inhibitors (n, %) | 115 (55%) | 56 (53%) | 59 (55%) | NS |
| Diuretics (thiazide or furosemide) (n, %) | 74 (36%) | 40 (39%) | 34 (33%) | NS |
| Anti-depressive medication (n, %) | 12 (6%) | 4 (4%) | 8 (8%) | NS |
*NS: p>0.05 between active group and TAU.